Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Annemarie Weissenbacher is active.

Publication


Featured researches published by Annemarie Weissenbacher.


Transplantation | 2012

Recipient and donor body mass index as important risk factors for delayed kidney graft function.

Annemarie Weissenbacher; Maximilian Jara; Hanno Ulmer; Matthias Biebl; Claudia Bösmüller; Stefan Schneeberger; Gert Mayer; Johann Pratschke; Robert Öllinger

Background. Obesity is increasingly impacting the overall health status and the global costs for health care. The increase in body mass index (BMI) is also observed in kidney allograft recipients and deceased organ donors. Methods. In a retrospective single-center study, we analyzed 1132 deceased donor kidney grafts, transplanted at our institution between 2000 and 2009 for recipient and donor BMI and its correlation with delayed graft function (DGF). Recipients/donors were classified according to their BMI (<18.5, 18.5–24.9, 25–29.9, and >30 kg/m2). DGF was defined as requirement for one dialysis within the first week after transplantation. Results. Overall DGF rate was 32.4%, mean recipient BMI was 23.64±3.75 kg/m2, and mean donor BMI was 24.69±3.44 kg/m2. DGF rate was 25.2%, 29.8%, 40.9%, and 52.6% in recipients with BMI less than 18.5, 18.5 to 24.9, 25 to 29.9, and more than 30 kg/m2, respectively (P<0.0001). Donor BMI less than 18.5, 18.5 to 24.9, 25 to 29.9, more than 30 kg/m2 resulted in a DGF rate of 22.5%, 31.0%, 37.3%, and 51.2% (P<0.0001). Multivariate analysis revealed recipient BMI and dialysis duration as independent risk factors for DGF. DGF results in inferior 1- and 5-year graft and patient survival. Conclusion. Recipient and donor BMI correlate with the incidence of DGF. Awareness thereof should have an impact on peri- and posttransplant measures in renal transplant recipients.


Hand Clinics | 2011

World Experience After More Than a Decade of Clinical Hand Transplantation: Update on the Innsbruck Program

Theresa Hautz; Timm O. Engelhardt; Annemarie Weissenbacher; Martin Kumnig; Bettina Zelger; Michael Rieger; Gerhard Rumpold; Marina Ninkovic; Markus Gabl; Hildegunde Piza-Katzer; Johann Pratschke; Raimund Margreiter; Gerald Brandacher; Stefan Schneeberger

Patients who have lost a hand or upper extremity face many challenges in everyday life. For some patients, reconstructive hand transplantation represents a reasonable option for anatomic reconstruction, restoring prehensile function with sensation and allowing them to regain daily living independence. The first clinical case of bilateral hand transplantation at University Hospital Innsbruck was realized on March 17th, 2000. A decade later, a total of 7 hands and forearms were transplanted in 4 patients. This article review the clinical courses of 3 bilateral hand transplant recipients and highlights psychological aspects on reconstructive hand transplantation with special regard to unilateral/bilateral transplantation.


Transplant International | 2014

Antibody‐mediated rejection in hand transplantation

Annemarie Weissenbacher; Theresa Hautz; Bernhard Zelger; Bettina Zelger; Verena Mayr; Gerald Brandacher; Johann Pratschke; Stefan Schneeberger

Clinical relevance of antibody‐mediated rejection (ABMR) in vascularized composite allotransplantation (VCA) has not been defined. We herein describe a novel type of donor‐specific antibody (DSA) and B‐cell‐associated rejection in hand transplantation. In 2003, a bilateral forearm transplantation was performed on a 42‐year‐old male patient. In 2012, the patient presented with edematous hands and forearms without skin lesions. Punch skin biopsies revealed rejection grade Banff II. Immunohistochemical analysis identified large aggregates of CD20 + lymphocytes with an architecture resembling lymph nodes. De novo DSA was found at a high level. Steroid treatment was ineffective, but administration of rituximab resulted in complete remission of clinical symptoms, evaporation of B‐cell aggregates, and disappearance of DSA. We herein report the first case of what we suggest is an ABMR in VCA occurring at 9 years after forearm transplantation. Rituximab therapy successfully reversed the event.


Annals of Surgery | 2012

Evolution of pancreas transplantation: long-term results and perspectives from a high-volume center.

Robert Öllinger; Christian Margreiter; Claudia Bösmüller; Annemarie Weissenbacher; Florian Frank; Stefan Schneeberger; Walter Mark; Raimund Margreiter; Johann Pratschke

Objective:To describe the evolution of pancreas transplantation from 1979 to 2011. The aim was to examine factors influencing long-term patient and graft survival, surgical methods, and risk factors influencing organ performance after transplantation. Background:Pancreas transplantation has become the therapy of choice for patients suffering insulin-dependent diabetes and end stage renal failure. Methods:Retrospective analysis of 509 consecutive pancreas transplants (442 simultaneous pancreas and kidney [SPK], 20 pancreas transplanted alone [PTA], and 47 pancreas transplanted after kidney [PAK]), performed at the University Hospital Innsbruck. The data were statistically analyzed using the Kaplan-Meier method and log-rank test. Results:After overcoming initial immunological and technical problems between 1979 and 1988 (5-year pancreas graft survival rate, 29.7%), pancreas transplantation evolved during the second decade (1989–1996; 5-year pancreas graft survival rate, 42.2%). Technical changes, optimized immunosuppression, careful pretransplant evaluation, and improved graft monitoring have become standard in the last decade and result in excellent 5-year patient (94.3%), kidney (89.4%), and pancreas (81.5%) graft survival. Five-year graft survival was superior in SPK (68.8%) compared with PAK (62.5%) and PTA (16.4%). SPK retransplantation can be carried out safely with 5-year patient (87.5%) and pancreas graft (75.0%) survival. Overall 5-year patient survival after loss of the first pancreas graft is significantly better in patients who underwent retransplantation (89.4% vs. 67.9%, P = 0.001). Long-term pancreas graft survival is independent of donor body mass index, sex, and cause of death, anastomosis time and the number of human leukocyte antigen (HLA) mismatches, recipient age, body mass index, sex, current panel reactive antibodies, and waiting time. Significant risk factors for reduced graft survival are cold ischemia time and donor age. Conclusions:During the last 32 years, many problems in pancreas transplantation have been overcome and it may currently represent the therapeutic gold standard for some patients with diabetes and end stage renal failure.


Nature | 2018

A randomized trial of normothermic preservation in liver transplantation

D Nasralla; Constantin C. Coussios; Hynek Mergental; M. Zeeshan Akhtar; Andrew J. Butler; C Ceresa; Virginia Chiocchia; Susan Dutton; Juan Carlos García-Valdecasas; Nigel Heaton; Charles J. Imber; Wayel Jassem; Ina Jochmans; John Karani; Simon R. Knight; Peri Kocabayoglu; Massimo Malago; Darius F. Mirza; Peter J. Morris; Arvind Pallan; Andreas Paul; Mihai Pavel; M. Thamara P. R. Perera; Jacques Pirenne; Reena Ravikumar; Leslie James Russell; Sara Upponi; Christopher J. E. Watson; Annemarie Weissenbacher; Rutger J. Ploeg

Liver transplantation is a highly successful treatment, but is severely limited by the shortage in donor organs. However, many potential donor organs cannot be used; this is because sub-optimal livers do not tolerate conventional cold storage and there is no reliable way to assess organ viability preoperatively. Normothermic machine perfusion maintains the liver in a physiological state, avoids cooling and allows recovery and functional testing. Here we show that, in a randomized trial with 220 liver transplantations, compared to conventional static cold storage, normothermic preservation is associated with a 50% lower level of graft injury, measured by hepatocellular enzyme release, despite a 50% lower rate of organ discard and a 54% longer mean preservation time. There was no significant difference in bile duct complications, graft survival or survival of the patient. If translated to clinical practice, these results would have a major impact on liver transplant outcomes and waiting list mortality.Normothermic machine perfusion of the liver improved early graft function, demonstrated by reduced peak serum aspartate transaminase levels and early allograft dysfunction rates, and improved organ utilization and preservation times, although no differences were seen in graft or patient survival.


Transplant International | 2012

The psychological assessment of candidates for reconstructive hand transplantation

Martin Kumnig; Sheila G. Jowsey; Gerhard Rumpold; Annemarie Weissenbacher; Theresa Hautz; Timm O. Engelhardt; Gerald Brandacher; Markus Gabl; Marina Ninkovic; Michael Rieger; Bernhard Zelger; Bettina Zelger; Michael Blauth; Raimund Margreiter; Johann Pratschke; Stefan Schneeberger

Standardized psychological assessment of candidates for reconstructive hand transplantation (RHT) is a new approach in transplantation medicine. Currently, international guidelines and standardized criteria for the evaluation are not established. Patients suffering from the loss of a hand or an upper extremity have to cope with multiple challenges. For a selected group of patients, RHT represents an option for restoring natural function and for regaining daily living independence. The identification of at‐risk patients and those requiring ongoing counseling due to poor coping or limited psychological resources are the primary focus of the psychological assessment. We have developed the ‘Innsbruck Psychological Screening Program for Reconstructive Transplantation (iRT‐PSP)’ which utilizes a semi‐structured interview and standardized psychological screening procedures and continuous follow‐up ratings. Between January 2011 and October 2011, four candidates were evaluated using the iRT‐PSP. Psychological impairments including social withdrawal, embarrassment, reduced self‐esteem, and a depressive coping style were identified and poor quality of life was reported. The motivation for transplantation was diverse, depending on many factors such as bi‐ or unilateral impairment, native or accidental loss of hand, and social integration.


Current Opinion in Organ Transplantation | 2013

Vascularized Composite Allografts and Solid Organ Transplants: Similarities and Differences

Annemarie Weissenbacher; Theresa Hautz; Johann Pratschke; Stefan Schneeberger

Purpose of reviewVascularized composite allotransplantation (VCA) is a treatment for complex tissue injuries and defects of extremities and face. During the past thirteen years, more than 100 VCA cases have been reported. Form and function restored with VCA have exceeded the results achieved with conventional surgical techniques. The review summarized the development in VCA over the past 12 months with references of and comparison with solid organ transplantation. Recent findingsThe highlights reported in the latest publications included a better understanding of topical immunosuppressants for prevention and treatment of VCA rejection, mechanisms of chronic rejection and minimization of immunosuppressive maintenance treatment using a cell-based protocol in human upper-extremity transplantation. SummaryWe herein summarize the progress made in VCA in the last year with a focus on new clinical immunosuppressive strategies and novel targets for immunosuppression and immunomodulation including the application of mesenchymal stem cells for transplant tolerance.


Transplant International | 2015

The faster the better: anastomosis time influences patient survival after deceased donor kidney transplantation

Annemarie Weissenbacher; Rupert Oberhuber; Benno Cardini; Sascha Weiss; Hanno Ulmer; Claudia Bösmüller; Stefan Schneeberger; Johann Pratschke; Robert Öllinger

Despite a continuously growing knowledge of the impact of factors on kidney graft function, such as donor age, body mass index, and cold ischemia time, few data are available regarding anastomosis time (AT) and its impact on long‐term results. We investigated whether surgical AT correlates with patient and graft survival after kidney transplantation performing a retrospective analysis of 1245 consecutive deceased donor kidney transplantations between 01/2000 and 12/2010 at Innsbruck Medical University. Kaplan–Meier and log‐rank analyses were carried out for 1‐ and 5‐year patient and graft survival. AT was defined as time from anastomosis start until reperfusion. Median AT was 30 min. Five‐year survival of allografts with an AT >30 min was 76.6% compared with 80.6% in the group with AT <30 min (P = 0.027). Patient survival in the group with higher AT similarly was inferior with 85.7% after 5 years compared with 89.6% (P < 0.0001) [Correction added on February 18, 2015, after first online publication: the percentage value for patient survival was previously incorrect and have now been changed to 89.6%]. Cox regression analysis revealed AT as an independent significant factor for patient survival (HR 1.021 per minute; 95% CI 1.006–1.037; P = 0.006). As longer AT closely correlates with inferior long‐term patient survival, it has to be considered as a major risk factor for inferior long‐term results after deceased donor kidney transplantation.


Transplant International | 2014

Lymphoid neogenesis in skin of human hand, nonhuman primate, and rat vascularized composite allografts

Theresa Hautz; Bettina Zelger; Isam W. Nasr; Gerhard S. Mundinger; Rolf N. Barth; Eduardo D. Rodriguez; Gerald Brandacher; Annemarie Weissenbacher; Bernhard Zelger; P. Cavadas; Raimund Margreiter; W. P. Andrew Lee; Johann Pratschke; Fadi G. Lakkis; Stefan Schneeberger

The mechanisms of skin rejection in vascularized composite allotransplantation (VCA) remain incompletely understood. The formation of tertiary lymphoid organs (TLO) in hand transplantation has been recently described. We assess this phenomenon in experimental and clinical VCA rejection. Skin biopsies of human (n = 187), nonhuman primate (n = 11), and rat (n = 15) VCAs were analyzed for presence of TLO. A comprehensive immunohistochemical assessment (characterization of the cell infiltrate, expression of adhesion molecules) including staining for peripheral node addressin (PNAd) was performed and correlated with rejection and time post‐transplantation. TLO were identified in human, nonhuman primate, and rat skin samples. Expression of PNAd was increased in the endothelium of vessels upon rejection in human skin (P = 0.003) and correlated with B‐ and T‐lymphocyte numbers and LFA‐1 expression. PNAd expression was observed at all time‐points after transplantation and increased significantly after year 5. In nonhuman primate skin, PNAd expression was found during inflammatory conditions early and late after transplantation. In rat skin, PNAd expression was strongly associated with acute rejection and time post‐transplantation. Lymphoid neogenesis and TLO formation can be uniformly found in experimental and human VCA. PNAd expression in vascular endothelium correlates with skin rejection and T‐ and B‐cell infiltration.


Thoracic Surgery Clinics | 2010

Robotic surgery of the mediastinum.

Annemarie Weissenbacher; Johannes Bodner

Several different mediastinal procedures for benign and malignant diseases have been proved to be feasible and safe when performed by a robotic minimally invasive approach. This article reviews the published data on robotic mediastinal surgery, focusing on technical aspects and perioperative outcomes. These are evaluated for differences and potential benefits over open and conventional minimally invasive techniques. Is there a need for the robot in the mediastinum? Is its application justified?

Collaboration


Dive into the Annemarie Weissenbacher's collaboration.

Top Co-Authors

Avatar

Stefan Schneeberger

Innsbruck Medical University

View shared research outputs
Top Co-Authors

Avatar

Raimund Margreiter

Innsbruck Medical University

View shared research outputs
Top Co-Authors

Avatar

Theresa Hautz

Innsbruck Medical University

View shared research outputs
Top Co-Authors

Avatar

Bettina Zelger

Innsbruck Medical University

View shared research outputs
Top Co-Authors

Avatar

Gerald Brandacher

Johns Hopkins University School of Medicine

View shared research outputs
Top Co-Authors

Avatar

Robert Öllinger

Innsbruck Medical University

View shared research outputs
Top Co-Authors

Avatar

Claudia Bösmüller

Innsbruck Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hanno Ulmer

Innsbruck Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge